A Collaboration of the Academy of Managed Care Pharmacy, the International Society for Pharmaeconomics and Outcomes Research and the National Pharmaceutical Council
The growing availability of new research methods poses challenges and opportunities for today’s formulary decision makers. There is little guidance on how to evaluate and use these new studies, creating a risk for two undesirable outcomes: new study data being misinterpreted or critical information not being used to inform decision-making. The CER Collaborative has developed online tools to address the need for real-world understanding and use of the new research being generated.
We are grateful for the contributions of many individuals: